Sarcopenia, an age-related loss of muscle mass and power, was recently recognised as a disease and received an International Classification of Diseases (ICD)-10 code M62.84 (September 2016). 1 The European Working Group on Sarcopenia in Older People (EWGSOP) defined it as a syndrome characterised by a progressive loss of skeletal muscle mass and strength associated with a risk of impairment, poor quality of life, and death. 2 The EWGSOP classified sarcopenia as primary, which is age related; and secondary, which includes sarcopenia related to physical inactivity (after prolonged bed rest, low physical activity, sedentary lifestyle), diseases (advanced organ failure, inflammatory, malignancy and endocrinopathy) and nutrition (inadequate diet, malabsorption, gastrointestinal disorders and drug-induced anorexia).
for 10 seconds (toe behind the heel). The second section is designed to assess the gait speed of 4 meters linear. The third section investigates the ability and the time taken to perform the sit to stand five consecutive times, without the aim of upper limbs. 7 However, it is possible to diagnose sarcopenia in daily clinical practice.
The SARC-F questionnaire includes five components, including strength, assistance walking, rise from a chair, climb stairs and falls. 7 The SARC-F scale scores range from 0 to 10 (i.e., 0-2 points for each component: 0=best to 10=worst in total score) and are categorised to represent symptomatic (4+) versus healthy (0-3) status. This questionnaire is globally validated. 
Management of sarcopenia in the elderly
One of the interventions for the prevention and treatment of sarcopenia is nutrition. It has been proven that older adults probably need 1.0-1.2 gr/kg protein intake per day. Creatine supplements, high vitamin D levels and other nutrients under investigation may provide further help. 9 The second important intervention is exercise, especially resistance exercise. Resistance-type exercise increases muscle strength and mass, which leads to improved physical performance. In order to stimulate muscle hypertrophy and increase strength, exercising at a low speed concentric and eccentric to each muscle for 2-3 seconds is safe, feasible and effective. Aerobic exercise appears good against sarcopenia as well because it increases mitochondrial energy production, insulin sensitivity and reduces oxidative stress. 10 However, the effective activity depends on proper nutrition.
Nowadays, there is an attempt to design medicines for sarcopenia prevention and treatment. 11 The anabolic hormone testosterone increases muscle mass, power, force and function, but can have very serious adverse effects, such as water retention, increase of hematocrit, worsening of sleep apnoea, increasing frequency of cardiovascular accidents and prostate events. Many other drugs are being tested in clinical trials to attempt to prove efficiency and safety in elderly population. This is a work in progress. 12 
